MedPath

Clinical verification of homoeopathic medicine Phyllanthus niruri

Phase 2
Conditions
Health Condition 1: J31- Chronic rhinitis, nasopharyngitisand pharyngitisHealth Condition 2: K590- ConstipationHealth Condition 3: R14- Flatulence and related conditionsHealth Condition 4: K591- Functional diarrheaHealth Condition 5: R51- HeadacheHealth Condition 6: R53- Malaise and fatigueHealth Condition 7: R11- Nausea and vomitingHealth Condition 8: M130- Polyarthritis, unspecifiedHealth Condition 9: K120- Recurrent oral aphthae
Registration Number
CTRI/2023/10/058802
Lead Sponsor
Central Council for Research in Homoeopathy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Participants presenting with minimum of three signs and symptoms corresponding to the signs and symptoms attributed to the medicines to be verified.

2. Participants presenting with acute or chronic clinical conditions as per the symptomatology mentioned in the ‘Materia Medica’ of the medicines to be verified.

3. Participants who are not taking any homoeopathic medication for their acute presenting complaints.

4. Participants who have not taken any homoeopathic medication for the past one week for their chronic complaints or those agreeing for a washout period of one week for discontinuing ongoing medications.

5. Participants willing to participate in the study and giving written informed consent/ assent.

Exclusion Criteria

1. Participants presenting with the clinical presentations other than the symptomatology mentioned in the ‘Materia Medica’ of the medicines to be verified.

2. Participants with a history of uncontrolled or life-threatening disease/ systemic illness (tuberculosis, cancer, AIDS, diabetes, hypertension, cardiovascular disorders etc.)

3. Any pre-existing psychiatric disorder.

4. Participants taking concomitant medications like immuno-suppressants, hormonal therapies or other Ayush therapies/ herbal medicines etc. for chronic ailments.

5. Substance abuse and/or dependence.

6. Pregnant and lactating women.

7. Participants deemed unfit by the investigator.

8. Participants not willing to give written informed consent/ assent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath